November 12, 2026

Myeloma in B&H marks a decade of advocacy and regional co-operation

Myeloma in B&H marks a decade of advocacy and regional co-operation

MPE member association “Myeloma in B&H” marked its 10th anniversary with a Regional Expert Meeting held in Sarajevo on 31 October 2026, bringing together approximately 100 participants from Bosnia and Herzegovina, Croatia, Serbia and Slovenia, including haematologists, patient organisations, healthcare institutions and partners.

The meeting celebrated ten years of patient advocacy while providing an opportunity to discuss the future of myeloma care and collaboration across the region.

Discussing treatment advances and access to care

A key objective of the meeting was to exchange knowledge and experience, discuss modern treatments for multiple myeloma and explore ways to improve patient access to medicines.

The scientific programme featured presentations from leading experts covering innovative therapies, bispecific antibodies, CAR-T therapy, minimal residual disease (MRD) monitoring, clinical practice and barriers to treatment access.

Strengthening regional patient advocacy

Regional cooperation was a central theme throughout the event. During a panel discussion titled From Patient Experience to Systemic Change – Ten Years of Advocacy and Regional Cooperation, representatives from patient organisations in Bosnia and Herzegovina, Croatia, Serbia and Slovenia shared experiences and discussed common challenges facing people affected by myeloma.

Participants highlighted the importance of ensuring that every patient, regardless of where they live, has timely access to effective medicines and high-quality treatment.

Celebrating ten years of impact

The anniversary provided an opportunity to reflect on the association’s achievements over the past decade and the partnerships that have supported its work. To mark the occasion, the organisation published a brochure documenting ten years of patient support, educational activities, treatment access advocacy, regional cooperation and international engagement with Myeloma Patients Europe (MPE) and the Global Myeloma Action Network (GMAN).

The association also presented anniversary awards and certificates of appreciation to healthcare professionals, institutions, patient organisations and partners who have contributed to its work over the years.

Looking ahead

The meeting concluded with a renewed focus on timely diagnosis, improved access to modern therapies, closer cooperation between healthcare professionals and patient organisations, and greater patient involvement in decisions about treatment and care. The association reaffirmed its commitment to supporting patients and strengthening regional and international partnerships in the years ahead.
Nataša Dragojević accepts an award